FDA Recently Approved Three Drugs to Treat Leukemia
Acute myeloid leukemia (AML) is a rapidly progressing cancer that forms in the bone marrow and results in an increased number of white blood cells in the bloodstream. The National […]
Read More →Acute myeloid leukemia (AML) is a rapidly progressing cancer that forms in the bone marrow and results in an increased number of white blood cells in the bloodstream. The National […]
Read More →Caffeine boosts enzyme that could protect against dementia A study by Indiana University researchers has identified 24 compounds – including caffeine – with the potential to boost an enzyme in […]
Read More →How to Prevent Dementia? (Part One) Memory loss is one striking feature of dementia. So, if you feel your memory gets worse and worse, then be cautious! That might be warning […]
Read More →On July 17, 2017, the U.S. Food and Drug Administration approved neratinib (Nerlynx, Puma Biotechnology, Inc.) for the extended adjuvant treatment of adult patients with early stage HER2-overexpressed/amplified breast cancer to […]
Read More →